At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 55 enrolled
Drug / intervention
Exparel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Does the Use of Liposomal Bupivacaine Decrease Narcotic Requirements in Geriatric Hip Fractures? A Randomized, Double Blinded Control Trial
In Brief
A Phase 4 clinical trial evaluating Exparel and Sodium Chloride for Hip Fractures. Completed, enrolled 55 participants across 2 sites.
Detailed Summary
This is a prospective, randomized study looking at the effect that a long-acting local anesthetic has on pain control in patients having surgery for hip fractures. The investigators are conducting the study to see if that reduces the amount of pain medicine needed after surgery, and if it reduces other medical complications after surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHip Fractures
CountriesUnited States
CollaboratorsOrthopaedic Trauma Association, University of Kentucky
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
Enrollment StartSep 2017
First PostedSep 2017
Primary CompletionJan 2019
Study CompletionJan 2019
TodayJul 2026
First PostedSep 21, 2017
Enrollment StartSep 1, 2017
Primary CompletionJan 1, 2019
Study CompletionJan 22, 2019
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.8 years ago
Interventions
Expareldrug
Subcutaneous injection at conclusion of surgical fixation of hip fracture
Sodium Chloridedrug
Saline Injection